Therese Sørlie

Publications by Therese Sørlie

51 publications found

Publications 2012

1. Kim J, Villadsen R, Sørlie T, Fogh L, Grønlund SZ, Fridriksdottir AJ, Kuhn I, Rank F, Wielenga VT, Solvang H, Edwards PA, Børresen-Dale AL, Rønnov-Jessen L, Bissell MJ, Petersen OW (2012)
   Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity
   Proc Natl Acad Sci U S A, 109 (16), 6124-9
   PubMed 22454501
2. Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sørlie T, Wärnberg F, Haakensen VD, Helland Å, Naume B, Perou CM, Haussler D, Troyanskaya OG, Børresen-Dale AL (2012)
   Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling
   Proc Natl Acad Sci U S A, 109 (8), 2802-7
   PubMed 21908711

Publications 2011

1. Akslen LA, Straume O, Geisler S, Sørlie T, Chi JT, Aas T, Børresen-Dale AL, Lønning PE (2011)
   Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer
   Br J Cancer, 105 (1), 9-12
   PubMed 21673677
2. Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjærde OC, Sørlie T, Børresen-Dale AL (2011)
   Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue
   Mol Oncol, 5 (6), 564-76
   PubMed 21917534
3. Sørlie T (2011)
   How to personalise treatment in early breast cancer
   Eur J Cancer, 47 Suppl 3, S310-1
   PubMed 21943994
4. Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale AL, Lingjærde OC (2011)
   Combining gene signatures improves prediction of breast cancer survival
   PLoS One, 6 (3), e17845
   PubMed 21423775

Publications 2010

1. Borgan E, Sitter B, Lingjærde OC, Johnsen H, Lundgren S, Bathen TF, Sørlie T, Børresen-Dale AL, Gribbestad IS (2010)
   Merging transcriptomics and metabolomics--advances in breast cancer profiling
   BMC Cancer, 10, 628
   PubMed 21080935
2. Børresen-Dale AL, Sørlie T, Kristensen VN (2010)
   On the molecular biology of breast cancer
   Mol Oncol, 4 (3), 171-3
   PubMed 20483673
3. Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F (2010)
   Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer
   Mol Oncol, 4 (4), 357-68
   PubMed 20663721
4. Muggerud AA, Rønneberg JA, Wärnberg F, Botling J, Busato F, Jovanovic J, Solvang H, Bukholm I, Børresen-Dale AL, Kristensen VN, Sørlie T, Tost J (2010)
   Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
   Breast Cancer Res, 12 (1), R3
   PubMed 20056007
5. Myhre S, Mohammed H, Tramm T, Alsner J, Finak G, Park M, Overgaard J, Børresen-Dale AL, Frigessi A, Sørlie T (2010)
   In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome
   PLoS One, 5 (11), e14002
   PubMed 21124964
6. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
   Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
   Mol. Oncol., 4 (2), 169
7. Podo F, Buydens LM, Degani H, Hilhorst R, Klipp E, Gribbestad IS, Van Huffel S, van Laarhoven HW, Luts J, Monleon D, Postma GJ, Schneiderhan-Marra N, Santoro F, Wouters H, Russnes HG, Sørlie T, Tagliabue E, Børresen-Dale AL, FEMME Consortium (2010)
   Triple-negative breast cancer: present challenges and new perspectives
   Mol Oncol, 4 (3), 209-29
   PubMed 20537966
8. Potapenko IO, Haakensen VD, Lüders T, Helland A, Bukholm I, Sørlie T, Kristensen VN, Lingjaerde OC, Børresen-Dale AL (2010)
   Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression
   Mol Oncol, 4 (2), 98-118
   PubMed 20060370
9. Russnes HG, Vollan HK, Lingjaerde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL (2010)
   Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
   Sci Transl Med, 2 (38), 38ra47
   PubMed 20592421
10. Sørlie T, Borgan E, Myhre S, Vollan HK, Russnes H, Zhao X, Nilsen G, Lingjaerde OC, Børresen-Dale AL, Rødland E (2010)
    The importance of gene-centring microarray data
    Lancet Oncol, 11 (8), 719-20; author reply 720-1
    PubMed 20688275

Publications 2009

1. Agarwal R, Gonzalez-Angulo AM, Myhre S, Carey M, Lee JS, Overgaard J, Alsner J, Stemke-Hale K, Lluch A, Neve RM, Kuo WL, Sorlie T, Sahin A, Valero V, Keyomarsi K, Gray JW, Borresen-Dale AL, Mills GB, Hennessy BT (2009)
   Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer
   Clin Cancer Res, 15 (11), 3654-62
   PubMed 19470724
2. Bergamaschi A, Hjortland GO, Triulzi T, Sørlie T, Johnsen H, Ree AH, Russnes HG, Tronnes S, Maelandsmo GM, Fodstad O, Borresen-Dale AL, Engebraaten O (2009)
   Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models
   Mol Oncol, 3 (5-6), 469-82
   PubMed 19713161
3. Muggerud AA, Edgren H, Wolf M, Kleivi K, Dejeux E, Tost J, Sørlie T, Kallioniemi O (2009)
   Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line
   BMC Med Genomics, 2, 26
   PubMed 19432969
4. Sørlie T (2009)
   Introducing molecular subtyping of breast cancer into the clinic?
   J Clin Oncol, 27 (8), 1153-4
   PubMed 19204193
5. Zhou W, Muggerud AA, Vu P, Due EU, Sørlie T, Børresen-Dale AL, Wärnberg F, Langerød A (2009)
   Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution
   Mol Oncol, 3 (3), 214-9
   PubMed 19403344

Publications 2008

1. Bergamaschi A, Tagliabue E, Sørlie T, Naume B, Triulzi T, Orlandi R, Russnes HG, Nesland JM, Tammi R, Auvinen P, Kosma VM, Ménard S, Børresen-Dale AL (2008)
   Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
   J Pathol, 214 (3), 357-67
   PubMed 18044827
2. Nordgard SH, Alnaes GI, Hihn B, Lingjaerde OC, Liestøl K, Tsalenko A, Sørlie T, Lønning PE, Børresen-Dale AL, Kristensen VN (2008)
   Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival
   Int J Cancer, 123 (3), 577-85
   PubMed 18498133

Publications 2007

1. Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G, Kåresen R, Nesland JM, Børresen-Dale AL, Sørlie T (2007)
   Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
   Mol Oncol, 1 (2), 160-71
   PubMed 19383292
2. Sørlie T (2007)
   Molecular classification of breast tumors: toward improved diagnostics and treatments
   Methods Mol Biol, 360, 91-114
   PubMed 17172726

Publications 2006

1. Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, Lonning PE, Tibshirani R, Børresen-Dale AL, Pollack JR (2006)
   Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer
   Genes Chromosomes Cancer, 45 (11), 1033-40
   PubMed 16897746
2. Kristensen VN, Edvardsen H, Tsalenko A, Nordgard SH, Sørlie T, Sharan R, Vailaya A, Ben-Dor A, Lønning PE, Lien S, Omholt S, Syvänen AC, Yakhini Z, Børresen-Dale AL (2006)
   Genetic variation in putative regulatory loci controlling gene expression in breast cancer
   Proc Natl Acad Sci U S A, 103 (20), 7735-40
   PubMed 16684880
3. Muggerud AA, Johnsen H, Barnes DA, Steel A, Lønning PE, Naume B, Sørlie T, Børresen-Dale AL (2006)
   Evaluation of MetriGenix custom 4D arrays applied for detection of breast cancer subtypes
   BMC Cancer, 6, 59
   PubMed 16536878
4. Sørlie T, Perou CM, Fan C, Geisler S, Aas T, Nobel A, Anker G, Akslen LA, Botstein D, Børresen-Dale AL, Lønning PE (2006)
   Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer
   Mol Cancer Ther, 5 (11), 2914-8
   PubMed 17121939
5. Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL (2006)
   Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms
   BMC Genomics, 7, 127
   PubMed 16729877

Publications 2005

1. Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sørlie T, Dai H, He YD, van't Veer LJ, Bartelink H, van de Rijn M, Brown PO, van de Vijver MJ (2005)
   Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
   Proc Natl Acad Sci U S A, 102 (10), 3738-43
   PubMed 15701700
2. Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL (2005)
   Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications
   Clin Cancer Res, 11 (2 Pt 2), 878s-83s
   PubMed 15701881
3. Kristensen VN, Sørlie T, Geisler J, Yoshimura N, Linegjaerde OC, Glad I, Frigessi A, Harada N, Lønning PE, Børresen-Dale AL (2005)
   Effects of anastrozole on the intratumoral gene expression in locally advanced breast cancer
   J Steroid Biochem Mol Biol, 95 (1-5), 105-11
   PubMed 16023338
4. Lønning PE, Sørlie T, Børresen-Dale AL (2005)
   Genomics in breast cancer-therapeutic implications
   Nat Clin Pract Oncol, 2 (1), 26-33
   PubMed 16264853
5. Sørlie T, Johnsen H, Vu P, Lind GE, Lothe R, Børresen-Dale AL (2005)
   Mutation screening of the TP53 gene by temporal temperature gradient gel electrophoresis
   Methods Mol Biol, 291, 207-16
   PubMed 15502225
6. Wolf M, Edgren H, Muggerud A, Kilpinen S, Huusko P, Sørlie T, Mousses S, Kallioniemi O (2005)
   NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer
   Cell Oncol, 27 (3), 169-73
   PubMed 16037637

Publications 2004

1. Sørlie T (2004)
   Molecular portraits of breast cancer: tumour subtypes as distinct disease entities
   Eur J Cancer, 40 (18), 2667-75
   PubMed 15571950
2. Troester MA, Hoadley KA, Sørlie T, Herbert BS, Børresen-Dale AL, Lønning PE, Shay JW, Kaufmann WK, Perou CM (2004)
   Cell-type-specific responses to chemotherapeutics in breast cancer
   Cancer Res, 64 (12), 4218-26
   PubMed 15205334

Publications 2003

1. Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, van de Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO et al. (2003)
   Gene expression patterns in ovarian carcinomas
   Mol Biol Cell, 14 (11), 4376-86
   PubMed 12960427
2. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lønning PE, Brown PO, Børresen-Dale AL, Botstein D (2003)
   Repeated observation of breast tumor subtypes in independent gene expression data sets
   Proc Natl Acad Sci U S A, 100 (14), 8418-23
   PubMed 12829800

Publications 2002

1. Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Børresen-Dale AL, Brown PO (2002)
   Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
   Proc Natl Acad Sci U S A, 99 (20), 12963-8
   PubMed 12297621

Publications 2001

1. Forus A, Sørlie T, Børresen-Dale AL, Myklebost O (2001)
   [Microarray technology--potential in cancer research]
   Tidsskr Nor Laegeforen, 121 (21), 2498-503
   PubMed 11875927
2. Lønning PE, Sørlie T, Perou CM, Brown PO, Botstein D, Børresen-Dale AL (2001)
   Microarrays in primary breast cancer--lessons from chemotherapy studies
   Endocr Relat Cancer, 8 (3), 259-63
   PubMed 11566617
3. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL (2001)
   Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
   Proc Natl Acad Sci U S A, 98 (19), 10869-74
   PubMed 11553815

Publications 2000

1. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børresen-Dale AL, Brown PO, Botstein D (2000)
   Molecular portraits of human breast tumours
   Nature, 406 (6797), 747-52
   PubMed 10963602

Publications 1999

1. Berner JM, Sørlie T, Mertens F, Henriksen J, Saeter G, Mandahl N, Brøgger A, Myklebost O, Lothe RA (1999)
   Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors: studies of CDKN2A and other genes of the pRB pathway
   Genes Chromosomes Cancer, 26 (2), 151-60
   PubMed 10469453

Publications 1998

1. Sørlie T, Andersen TI, Bukholm I, Børresen-Dale AL (1998)
   Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases
   Breast Cancer Res Treat, 48 (3), 259-64
   PubMed 9598872
2. Sørlie T, Bukholm I, Børresen-Dale AL (1998)
   Truncating somatic mutation in exon 15 of the APC gene is a rare event in human breast carcinomas. Mutations in brief no. 179. Online
   Hum Mutat, 12 (3), 215
   PubMed 10660330
3. Sørlie T, Martel-Planche G, Hainaut P, Lewalter J, Holm R, Børresen-Dale AL, Montesano R (1998)
   Analysis of p53, p16MTS, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines
   Br J Cancer, 77 (10), 1573-9
   PubMed 9635831

Publications 1995

1. Esteve A, Sørlie T, Martel-Planche G, Hollstein M, Kusters I, Lewalter J, Vineis P, Stephan-Odenthal M, Montesano R (1995)
   Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors
   J Occup Environ Med, 37 (1), 59-68
   PubMed 7620944

Publications 1994

1. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sørlie T, Hovig E, Smith-Sørensen B, Montesano R, Harris CC (1994)
   Database of p53 gene somatic mutations in human tumors and cell lines
   Nucleic Acids Res, 22 (17), 3551-5
   PubMed 7937055